Updated: January 15, 2016
Released: January 4, 2016

Defense Health Program
Department of Defense Bone Marrow Failure Research Program
Funding Opportunities for Fiscal Year 2016 (FY16)

The FY16 Defense Appropriations Act provides $3 million to the Department of Defense Bone Marrow Failure Research Program (BMFRP) to support innovative research committed to advancing the understanding of inherited and acquired bone marrow failure diseases. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, Research and Development and Acquisition (DHA RDA) Directorate manages the Defense Health Program (DHP) Research, Development, Test and Evaluation (RDT &E) appropriation. The managing agent for the anticipated Program Announcement/Funding Opportunity is the Congressionally Directed Medical Research Programs (CDMRP).

The BMFRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. The FY16 BMFRP Program Announcement and General Application Instructions for the following award mechanism are anticipated to be posted on the website in February 2016. Pre-application and application deadlines will be available when the Program Announcement is released. This pre-announcement should not be construed as an obligation by the Government.

Award Mechanism Eligibility Key Mechanism Elements Funding
Idea Development Award
  • Established Investigators:
    Investigators at or above the level of Associate Professor (or equivalent) are eligible to apply.
  • Early-Career Investigators:
    Investigators at the level of Assistant Professor, Instructor, or Assistant Research Professor (or equivalent) and less than 10 years from their terminal degree (excluding time spent in medical residency, or during family medical leave) at the time of application submission deadline are eligible to apply.
  • Supports innovative ideas and high-impact approaches based on scientifically sound evidence in order to move toward the vision to understand and cure BMF.
  • Strong BMF research team.
  • May include relevant preliminary data.
  • Clinical trials will not be supported.
  • Pre-application required.
  • Full application submission by invitation only.
  • Maximum funding of $315,000 in direct costs (plus indirect costs)
  • Period of performance not to exceed 2 years

All applications must conform to the final Program Announcement and General Application Instructions that will be available for electronic downloading from the website. Applications must be submitted through the federal government's single-entry portal, The application package containing the required forms for the award mechanism will also be found on A listing of all USAMRMC funding opportunities can be obtained on the website by performing a basic search using CFDA Number 12.420.

A pre-application is required and must be submitted through the CDMRP electronic Biomedical Research Application Portal (eBRAP) website ( prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Submission deadlines are not available until the Program Announcement is released. Requests for email notification of the Program Announcement release may be sent to Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor for official postings of funding opportunities.

For more information about the BMFRP or other CDMRP-administered programs, please visit the CDMRP website (

Point of Contact:

CDMRP Public Affairs

Last updated Thursday, May 26, 2022